NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease

Brian Lawlor, Sean Kennelly, Sarah O'Dwyer, Fiona Cregg, Cathal Walsh, Robert Coen, Rose Anne Kenny, Robert Howard, Caroline Murphy, Jessica Adams, Leslie Daly, Ricardo Segurado, Siobhan Gaynor, Fiona Crawford, Michael Mullan, Ugo Lucca, Rita Banzi, Florence Pasquier, Laetitia Breuilh, Matthias RiepeJanos Kalman, Anders Wallin, Anne Borjesson, William Molloy, Magda Tsolaki, Marcel Olde Rikkert

Old Age Psychiatry
NIHR Maudsley Biomedical Research Centre (BRC)
Clinical Trials Unit Denmark Hill

Trinity College Dublin
UCD University College Dublin
Molecular Medicine Ireland (MMI)
Archer Pharmaceuticals Inc
Istituto di Ricerche Farmacologiche Mario Negri
Centre Hospitalo Universitaire De Lille
University of Ulm
University of Szeged
University of Gothenburg
University College Cork
Aristotle University of Thessaloniki
Radboud University Medical Center

Research output: Contribution to journal › Article › peer-review

37 Citations (Scopus)

Sort by
Weight
Alphabetically

NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease

Fingerprint

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science